Tag: psilocybin

Dave HodesMarch 17, 2022
shutterstock_1959297163.jpg

11min00
Psilocybin is the focus of more researchers and more business developers than ever before as study after study demonstrate its range of effectiveness.  In fact, to date, over 27,000 scientific articles have been published on psychedelic drugs, with over 1,000 particularly on psilocybin as of May, 2021, according to one study that also found that […]

Dave HodesFebruary 9, 2022
shutterstock_1763248556.jpg

9min00
As more research has been demonstrating, psilocybin may be one of the best new treatments for not only treatment-resistant depression, but also Alzheimer’s, post-traumatic stress disorder, autism, alcoholism, smoking, and drug addiction, anxiety, obsessive-compulsive disorder, cluster headaches, and more.  In fact, there are currently 50 psilocybin-related studies in the U.S. either active, completed, or recruiting. […]

Dave HodesJanuary 13, 2022
mushroom.jpg

10min00
On December 20, 2021, breakthrough research at the Usona Institute, a 501(c)(3) non-profit medical research organization based in Madison, Wisconsin, revealed the true crystal forms of pharmaceutical psilocybin. It’s a new discovery of characteristics of the polymorphs of the plant that have always existed but were not detected until now. But that discovery has ignited […]

StaffNovember 2, 2021
mushroom.jpg

3min01
Exclusively-natural psychedelic drug discovery company Filament Health Corp. (OTCQB: FLHLF) (NEO: FH)  received authorization from the FDA authorization to initiate the first clinical trial using naturally-sourced psychedelic substances. The news caused the stock to jump over 11% in early trading. The company said that this approval is the first for the direct administration of psilocin rather […]

StaffJune 3, 2021
shutterstock_1694533150.jpg

3min00
Silo Wellness Inc. (CSE: SILO) has signed a letter of intent with Canadian-based mushroom company Mushe Inc. to create the first legal functional and psychedelic mushroom retail outlet based in Jamaica. Silo Wellness currently cultivates psilocybin mushrooms, conducts psychedelic wellness retreats, and is testing a proof-of-concept patent-pending nasal spray. “As a company, we are very […]

Debra BorchardtJanuary 26, 2021
Psilocybin.jpg

3min00
As the race to own the psilocybin market heats up, MagicMed Industries Inc. (CSE: MGIC reserved)  announced that it has completed the establishment of the psilocybin-derivatives patent portfolio of the Psybrary and the launch of the Candidate Selection program.  The company said that Psybrary is a proprietary physical and knowledgebase collection of novel psychedelic-derivative drug candidates, […]

Get the latest cannabis news delivered right to your inbox

The Morning Rise

Unpack the industry with the daily cannabis newsletter for business leaders.

 Sign up


About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


READ MORE



Recent Tweets

Get the latest cannabis news delivered right to your inbox

The Morning Rise

Unpack the industry with the daily cannabis newsletter for business leaders.